Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. uri icon

Overview

publication date

  • August 1, 2008

Research

keywords

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Retinopathy of Prematurity
  • Vascular Endothelial Growth Factor A

Identity

Scopus Document Identifier

  • 49449116019

Digital Object Identifier (DOI)

  • 10.1001/archophthalmol.2008.1

PubMed ID

  • 18695118

Additional Document Info

volume

  • 126

issue

  • 8